14 results
8-K
EX-99.1
CLSD
Clearside Biomedical Inc
25 Jul 18
Regulation FD Disclosure
4:19pm
Treatment Groups Characteristic CLS-TA N=96 Control N=64 Overall N=160 Gender, n (%) Male 42 (43.8) 30 (46.9) 72 (45.0) Female 54 (56.3) 34 (53.1) 88
PRE 14A
CLSD
Clearside Biomedical Inc
19 Apr 22
Preliminary proxy
4:36pm
Board Diversity Matrix (As of April 18, 2022)
Board size
Gender
Male
Female
Non-Binary
Gender Undisclosed
Number of directors based on gender identity … experiences, and backgrounds, including age, gender, race, ethnicity, and country of origin. We believe that the judgment and perspectives offered
DRS/A
EX-10
yntx3frhlh1y 5o
9 Sep 14
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next